1. Home
  2. SRFM vs CING Comparison

SRFM vs CING Comparison

Compare SRFM & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Surf Air Mobility Inc.

SRFM

Surf Air Mobility Inc.

HOLD

Current Price

$1.13

Market Cap

84.7M

ML Signal

HOLD

CING

Cingulate Inc.

HOLD

Current Price

$5.24

Market Cap

93.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRFM
CING
Founded
2011
2012
Country
United States
United States
Employees
N/A
13
Industry
Transportation Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
84.7M
93.1M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
SRFM
CING
Price
$1.13
$5.24
Analyst Decision
Hold
Strong Buy
Analyst Count
3
2
Target Price
$3.25
$34.50
AVG Volume (30 Days)
3.7M
401.9K
Earning Date
05-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
45.69
N/A
EPS
N/A
N/A
Revenue
$106,557,000.00
N/A
Revenue This Year
$25.90
N/A
Revenue Next Year
$20.72
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.04
$3.20
52 Week High
$9.35
$11.89

Technical Indicators

Market Signals
Indicator
SRFM
CING
Relative Strength Index (RSI) 41.26 39.61
Support Level $1.07 $4.94
Resistance Level $1.46 $6.85
Average True Range (ATR) 0.13 0.44
MACD 0.02 0.01
Stochastic Oscillator 15.38 10.53

Price Performance

Historical Comparison
SRFM
CING

About SRFM Surf Air Mobility Inc.

Surf Air Mobility Inc is a regional air mobility platform operating commuter airlines in the United States and expanding an on-demand charter marketplace for passengers in the U.S. and globally. It is also focused on developing a proprietary aviation software, aircraft electrification powertrain technology and services to enable electrification across the regional air mobility sector. The company operates in a single reportable segment, Air Mobility. The Air Mobility segment derives revenue from operating scheduled commercial air service flights, which are sold to the public mainly on a per-seat basis; through subsidized EAS revenue awards from the Department of Transportation; and by operating on-demand flights for customers on an ad-hoc, by request basis.

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

Share on Social Networks: